X4 Pharmaceuticals, Inc.XFORNASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank90
3Y CAGR+17.2%
5Y CAGR+15.8%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+17.2%/yr
vs +33.0%/yr prior
5Y CAGR
+15.8%/yr
Consistent
Acceleration
-15.8pp
Decelerating
Percentile
P90
Near historical high
vs 5Y Ago
2.1x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $43.52M | -29.3% |
| 2024 | $61.52M | +73.3% |
| 2023 | $35.51M | +31.4% |
| 2022 | $27.02M | +9.4% |
| 2021 | $24.70M | +18.0% |
| 2020 | $20.94M | +31.1% |
| 2019 | $15.97M | +84.9% |
| 2018 | $8.64M | +10.6% |
| 2017 | $7.81M | +25.7% |
| 2016 | $6.21M | - |